1) Stirofos;Tetrachlorvinphos
司替罗磷
2) Stepronin
司替罗宁
3) Rolls-Royce company
罗罗公司
4) Roxatidine
罗沙替丁
1.
Optimization of Roxatidine Sustained-release Tablet by Spherical Symmetric Design and Its Releasability Study;
球面对称设计筛选罗沙替丁缓释片的处方及其释放度考察
2.
Determination of Roxatidine Hydrochioride in Human Serum by HPLC;
HPLC法测定血浆中盐酸罗沙替丁的含量
3.
Roxatidine Injection Used in Treatment of Patients with Hemorrhage of Upper Digestive Tract Caused by Peptic Ulcer or Acute Gastric Mucosal Lesion;
罗沙替丁治疗消化性溃疡或急性胃黏膜病变引起上消化道出血的临床研究
5) rotigotine
罗替戈汀
1.
Pharmacological and clinical studies of rotigotine transdermal patch;
罗替戈汀透皮贴剂的药理及临床研究进展
2.
The chiral analysis method of Rotigotine and its structurally-related impurities was developed.
本论文利用毛细管电泳对手性污染物(抑霉唑、右旋反式烯丙菊酯)的对映体进行了分离和相关检测,建立了抗帕金森药物罗替戈汀及其相关手性杂质的分离分析方法,并研究了其对血清白蛋白的对映体特异性结合。
3.
Foreign clinical results show that rotigotine is safe tolerance and effective drug for the early period of Parkinson\'s disease,and for later period Parkinson\'s disease ,it can be a supplementary drug of L-dopamine.
罗替戈汀(Rotigotine)为非麦角碱多巴胺受体兴奋剂,对D3/D2/D1有立体选择性,它直接作用于上述受体从而直接兴奋多巴按受体,改善震颤和运动障碍症状,降低肌张力,起到与多巴胺相似的作用。
6) Tirofiban
替罗非班
1.
Investigation of the Efficacy and Safety of Tirofiban in Elderly Patients with Acute Coronary Syndromes Referred to Percutaneous Coronary Intervention;
替罗非班对老年急性冠脉综合征患者行PCI术的疗效及安全性分析
2.
Clinical investigation of Tirofiban in influence of percutaneous coronary intervention for complex coronary artery disease;
替罗非班对冠脉复杂病变介入治疗影响分析
3.
Effects of tirofiban on dose of heparin and platelet aggregation in patients with acute coronary artery syndrome;
替罗非班对急性冠状动脉综合征肝素剂量及血小板的影响
补充资料：司替罗宁
分子式：C10H11NO4S2
分子量：273.32
CAS号：72324-18-6
性质：
分子量：273.32
CAS号：72324-18-6
性质：
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条